# Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

> **NCT05909137** · — · NOT_YET_RECRUITING · sponsor: **Xinqiao Hospital of Chongqing** · enrollment: 60 (estimated)

## Conditions studied

- Immunotherapy
- Intensity Modulated Radiation Therapy
- Radiotherapy
- NSCLC

## Interventions

- **RADIATION:** IMRT+adjuvant immunotherapy

## Key facts

- **NCT ID:** NCT05909137
- **Lead sponsor:** Xinqiao Hospital of Chongqing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05909137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05909137, "Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05909137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*